GSK3B and diabetes mellitus: Mechanically, BBR inhibits ERS via GSK-3β [18, 19] and is thought to improve diabetes mellitus and glucolipid metabolism disorders induced by liver injury by blocking ERS by GSK-3β [20, 21].